MICRUSFRAME MFR180612Recalls & reported problems
Cerenovus, Inc. · MICRUSFRAME S Microcoil 18 Stretch Resistant Coil and Detachable Coil System Contents: 1 Detachable Coil System Coil Type: MICRUSFRAME S 18 Stretch Resistant Coil 6mm (coil diameter) x 12.2cm (coil length) 190cm (working length) · Class 2 · Implant
All models of MICRUSFRAME (47)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10886704078197), received between Feb 8, 2017 and Feb 3, 2025 — classified as 4 injuries, 1 malfunction.
The most frequently reported specific device problem is “Failure to Advance” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Failure to Advance1
- Positioning Problem1
- Stretched1
Patient problems
- Aneurysm2
- Thromboembolism2
- Ischemia Stroke1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryFeb 3, 2025Stretched; Positioning Problem; Stretched; Positioning Problem
IT WAS REPORTED, VIA A HEALTHCARE PROFESSIONAL, THAT A MICRUSFRAME18 6MM X 12.2CM (MFR180612/ 30751838) WAS USED FOR AN ENDOVASCULAR EMBOLIZATION PROCEDURE TO TREAT A RUPTURED ANEURYSM OF THE LEFT POSTERIOR COMMUNICATING ARTERY. IT WAS DISCLOSED THAT ¿THE VESSEL LEADING UP TO THE ANEURYSM NECK WAS VERY DYSPLASTIC (ALMOST BALLOON LIKE).¿ DURING THE PROCEDURE, THE USER REPORTED DIFFICULTY POSITIONING THE COIL AND COIL -UNRAVELING/STRETCHED DURING PLACEMENT. THE PHYSICIAN THEN CUT THE PROXIMAL PORTION OF THE MICROCATHETER (EXCELSIOR SL-10 MICROCATHETER; STRYKER) AND REMOVED THE COIL AND THE SEPARATED PORTION OF THE MICROCATHETER BY DEPLOYING A MICRO-SNARE. THE PHYSICIAN THEN DEPLOYED A MICRUSFRAME 10 5MM X 9.7CM SUCCESSFULLY ALONG WITH SUBSEQUENT MICROVENTION COILS TO A SATISFACTORY RESULT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED AND WAS NOT DELAYED DUE TO THE REPORTED EVENT. NO CLINICAL CONSEQUENCES OCCURRED. NO DEVICE FRAGMENTS WERE GENERATED FROM THE EVENT. NO OTHER MEDICAL INTERVENTION WAS REQUIRED. IT WAS FURTHER NOTED, ¿AFTER THE CASE THE PHYSICIAN NOTED THAT HE DIDN'T FEEL THAT THE COIL WAS AT FAULT FOR THE STRETCHING, AND IT WAS DUE TO ¿OVER-MANIPULATION¿ BY HIM IN TRYING TO
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21293820 ↗InjuryJun 8, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE EVENT WAS REPORTED VIA THE STERLING STUDY, A 52-YEAR-OLD FEMALE PATIENT WITH A HISTORY OF HYPOTHYROIDISM UNDERWENT COIL EMBOLIZATION OF A RUPTURED LEFT MIDDLE CEREBRAL ARTERY (MCA) SIDE WALL ANEURYSM ON (B)(6) 2022. THE HUNT & HESS GRADE WAS 3, THE MODIFIED RANKIN SCALE (MRS) SCORE WAS 0. THE DIMENSIONS OF THE TARGET ANEURYSM WAS AS FOLLOWS: HEIGHT 4.1MM, DOME 5.1MM, MAXIMUM ANEURYSM DIAMETER 5.6MM, NECK SIZE 2.2MM, AND DOME-TO-NECK RATIO OF 2.3MM. THE PARENT VESSEL DIAMETER WAS 1.7MM. COIL EMBOLIZATION WAS PERFORMED USING THREE (3) CERENOVUS COILS: A 4MM X 7.5CM MICRUSFRAME 10 ((B)(6)/ 30686615), A 3MM X 4CM GALAXY G3 XSFT ((B)(6)/ 30483248), AND A 2MM X 2CM GALAXY G3 XSFT ((B)(6)/ 30583817) VIA AN SL-10® MICROCATHETER (STRYKER). IN THE OPINION OF THE INVESTIGATOR, TREATMENT OF THE TARGET ANEURYSM WAS CONSIDERED COMPLETE, AND THE STUDY COILS WERE SUCCESSFULLY IMPLANTED AT THE TARGET SITE. ANGIOSUITE PACKING DENSITY WAS NOT MENTIONED. IMMEDIATE POST-PROCEDURE MODIFIED RAYMOND-ROY CLASSIFICATION SCORE WAS CLASS I: COMPLETE = COMPLETE OBLITERATION. THERE WERE NO REPORTED STUDY DEVICE DEFICIENCIES OR INTRAOPERATIVE COMPLICATIONS DURING THE INDEX PROCEDURE. ON (B)(6) 2023, THE PATI
Patient problems: Ischemia Stroke
MAUDE report 17093089 ↗InjuryDec 15, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED BY THE STERLING STUDY, A 53-YEAR-OLD MALE FEMALE PATIENT (B)(6), UNDERWENT COIL EMBOLIZATION OF A RUPTURED RIGHT ANTERIOR CIRCULATION ANEURYSM AT THE POSTERIOR COMMUNICATING ARTERY ON (B)(6) 2021. IMMEDIATE MODIFIED RANKING SCALE (MRS) SCORE WAS 0 AND HUNT & HESS GRADE 3- DROWSINESS/CONFUSION, MILD FOCAL NEUROLOGIC DEFICIT. PER IMMEDIATE PRE-PROCEDURE DIGITAL SUBTRACTION ANGIOGRAPHY PERFORMED THE ANEURYSM HAD THE FOLLOWING DIMENSIONS: HEIGHT 12.8MM, DOME 11.1MM, MAXIMUM ANEURYSM DIAMETER 12.8MM, NECK SIZE 3.8MM, AND THE DOME-TO-NECK RATIO OF 2.9MM. THE PARENT VESSEL DIAMETER WAS 3.7MM. COIL EMBOLIZATION WAS PERFORMED USING THE FOLLOWING SIXTEEN (16) CERENOVUS COILS: GALAXY G3 XTRASOFT 2MM X 8CM (GLX120208, 30485189), TWO MICRUSFRAME18 8MM X 30CM (MFR180830,30593195), MICRUSFRAME18 6MM X 12.2CM (MFR180612, L16774), MICRUSFRAME10 5MM X 17CM (MFR100517,30593189), MICRUSFRAME18 6MM X 12.2CM (MFR180612, K10010), GALAXY G3 XSFT 4MM X 10CM (GLX120410, K10380), MICRUSFRAME14 12MM X 30CM (MFR141230, L15281), GALAXY G3 XSFT 3MM X 6CM (GLX120306, L16504), GALAXY G3 XSFT 4MM X 10CM (GLX120410, 30571101), GALAXY G3 XSFT 3MM X 8CM (GLX120308, 30513169), GALAXY G3 XSFT 2.5MM X 5CM (GL
Patient problems: Aneurysm; Thromboembolism
MAUDE report 15987130 ↗InjuryDec 15, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED BY THE STERLING STUDY, A 53-YEAR-OLD MALE FEMALE PATIENT (B)(6), UNDERWENT COIL EMBOLIZATION OF A RUPTURED RIGHT ANTERIOR CIRCULATION ANEURYSM AT THE POSTERIOR COMMUNICATING ARTERY ON (B)(6) 2021. IMMEDIATE MODIFIED RANKING SCALE (MRS) SCORE WAS 0 AND HUNT & HESS GRADE 3- DROWSINESS/CONFUSION, MILD FOCAL NEUROLOGIC DEFICIT. PER IMMEDIATE PRE-PROCEDURE DIGITAL SUBTRACTION ANGIOGRAPHY PERFORMED THE ANEURYSM HAD THE FOLLOWING DIMENSIONS: HEIGHT 12.8MM, DOME 11.1MM, MAXIMUM ANEURYSM DIAMETER 12.8MM, NECK SIZE 3.8MM, AND THE DOME-TO-NECK RATIO OF 2.9MM. THE PARENT VESSEL DIAMETER WAS 3.7MM. COIL EMBOLIZATION WAS PERFORMED USING THE FOLLOWING SIXTEEN (16) CERENOVUS COILS: GALAXY G3 XTRASOFT 2MM X 8CM (GLX120208, 30485189), TWO MICRUSFRAME18 8MM X 30CM (MFR180830,30593195), MICRUSFRAME18 6MM X 12.2CM (MFR180612, L16774), MICRUSFRAME10 5MM X 17CM (MFR100517,30593189), MICRUSFRAME18 6MM X 12.2CM (MFR180612, K10010), GALAXY G3 XSFT 4MM X 10CM (GLX120410, K10380), MICRUSFRAME14 12MM X 30CM (MFR141230, L15281), GALAXY G3 XSFT 3MM X 6CM (GLX120306, L16504), GALAXY G3 XSFT 4MM X 10CM (GLX120410, 30571101), GALAXY G3 XSFT 3MM X 8CM (GLX120308, 30513169), GALAXY G3 XSFT 2.5MM X 5CM (GL
Patient problems: Aneurysm; Thromboembolism
MAUDE report 15987100 ↗MalfunctionFeb 8, 2017Failure to Advance; Failure to Advance
THE CONTACT FROM THE FACILITY REPORTED THAT WHILE TREATING A RUPTURED ANTERIOR COMMUNICATING ARTERY (ACOM) ANEURYSM THE DOCTOR COULD NOT ADVANCE THE MICRUSFRAME COIL (MFR180612/C41978) THROUGH THE LAST 1 CM OF THE DISTAL END OF THE STRYKER XT-17 MICROCATHETER (DETAILS UNKNOWN.) THERE WAS NO VISIBLE DAMAGE TO THIS MICROCATHETER. HE TRIED SEVERAL TIMES AND WAS ABLE TO PULL THE COIL BACK AND ADVANCE, BUT ONCE IT HIT THE SAME SPOT IN THE MICROCATHETER IT WOULD STOP ADVANCING. HE REMOVED THE COIL AND MICROCATHETER AND ACCESSED THE ANEURYSM WITH A NEW XT-17 AND WAS ABLE TO PLACE 6 SPECTRA COILS (DETAILS UNKNOWN) SUCCESSFULLY. THERE WAS NO DELAY GREATER THAN 30 MINUTES DUE TO THE ISSUE. THERE WAS NO DAMAGE TO ANY PART OF THE MICRUSFRAME DEVICE AFTER IT WAS REMOVED. AN ADEQUATE CONTINUOUS FLUSH WAS MAINTAINED THROUGH THE MICROCATHETER.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6313168 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page